Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Probucol"" wg kryterium: Temat


Tytuł:
Probucol attenuates high glucose-induced Müller cell damage through enhancing the Nrf2/p62 signaling pathway.
Autorzy:
Zhou YF; Department of Ophthalmology, Aier Eye Hospital of Changsha, Changsha, 410015, Hunan Province, China.; Aier School of Ophthalmology, Central South University, Changsha, 410015, Hunan Province, China.
Liu HW; Department of Ophthalmology, Aier Eye Hospital of Changsha, Changsha, 410015, Hunan Province, China.; Aier School of Ophthalmology, Central South University, Changsha, 410015, Hunan Province, China.
Yang X; Aier Eye Research Laboratory, Aier Eye Institute, Changsha, 410015, Hunan Province, China.
Li CX; Department of Ophthalmology, Aier Eye Hospital of Changsha, Changsha, 410015, Hunan Province, China.; Aier School of Ophthalmology, Central South University, Changsha, 410015, Hunan Province, China.
Chen JS; Aier School of Ophthalmology, Central South University, Changsha, 410015, Hunan Province, China.; Medical College, Jinan University, Guangzhou, 510632, Guangdong Province, China.
Chen ZP; Department of Ophthalmology, Aier Eye Hospital of Changsha, Changsha, 410015, Hunan Province, China. .; Aier School of Ophthalmology, Central South University, Changsha, 410015, Hunan Province, China. .; The First Clinical Medical College of Jinan University, Guangzhou, 510000, China. .; School of Stomatology and Ophthalmology, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, China. .
Pokaż więcej
Źródło:
International ophthalmology [Int Ophthalmol] 2023 Dec; Vol. 43 (12), pp. 4595-4604. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Ependymoglial Cells*/drug effects
Ependymoglial Cells*/metabolism
Probucol*/pharmacology
Signal Transduction*
Humans ; Glucose/metabolism ; Glucose/pharmacology ; NF-E2-Related Factor 2
Czasopismo naukowe
Tytuł:
Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Autorzy:
Wang X; Department of Biobank, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Zhang W; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Zeng S; Clinical Stem Cell Center, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China.
Wang L; Clinical Stem Cell Center, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China.
Wang B; Clinical Stem Cell Center, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2024 Feb; Vol. 175, pp. 262-278. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatic Stellate Cells*/metabolism
Nanoparticles*
Mice ; Animals ; Probucol/pharmacology ; Probucol/metabolism ; Probucol/therapeutic use ; Reactive Oxygen Species/metabolism ; Liver Cirrhosis/metabolism ; Liver/pathology ; Extracellular Matrix/metabolism ; Collagen/metabolism ; Collagen Type I/metabolism ; Collagenases/metabolism ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases.
Autorzy:
Sharif A; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Mamo J; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.; Perron Institute for Neurological and Translational Research, Perth, WA, Australia.
Lam V; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.; School of Public Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Al-Salami H; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Mooranian A; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Watts GF; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia.
Clarnette R; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia.
Luna G; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Takechi R; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia. .; School of Public Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia. .
Pokaż więcej
Źródło:
Translational neurodegeneration [Transl Neurodegener] 2024 Jan 22; Vol. 13 (1), pp. 6. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neurodegenerative Diseases*/drug therapy
Alzheimer Disease*
Parkinson Disease*
Humans ; Probucol/therapeutic use ; Blood-Brain Barrier
Czasopismo naukowe
Tytuł:
Inhibition of the cholesterol transporter ABCA1 by probucol decreases capacitation and tyrosine phosphorylation of dog spermatozoa, and is dose dependent.
Autorzy:
Schäfer-Somi S; Platform for Artificial Insemination and Embryo Transfer, Department for Small Animals and Horses, University of Veterinary Medicine, Veterinärplatz 1, 1210, Vienna, Austria. Electronic address: .
Claaßen S; Platform for Artificial Insemination and Embryo Transfer, Department for Small Animals and Horses, University of Veterinary Medicine, Veterinärplatz 1, 1210, Vienna, Austria.
Lechner D; Platform for Artificial Insemination and Embryo Transfer, Department for Small Animals and Horses, University of Veterinary Medicine, Veterinärplatz 1, 1210, Vienna, Austria.
Pokaż więcej
Źródło:
Theriogenology [Theriogenology] 2023 Feb; Vol. 197, pp. 159-166. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Probucol*/pharmacology
Probucol*/metabolism
Semen*/metabolism
Dogs ; Male ; Animals ; Phosphorylation ; Sperm Motility/physiology ; Spermatozoa/physiology ; Cholesterol/metabolism ; Sperm Capacitation ; Acrosome Reaction ; Tyrosine/pharmacology ; Tyrosine/metabolism
Czasopismo naukowe
Tytuł:
An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets.
Autorzy:
Moskal N; Department of Biochemistry, University of Toronto, Toronto, Canada.
Visanji NP; Edmund J Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Canada.
Gorbenko O; Department of Biochemistry, University of Toronto, Toronto, Canada.
Narasimhan V; Zebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital and Department of Medicine and Physiology, University of Toronto, Toronto, Canada.
Tyrrell H; Department of Biochemistry, University of Toronto, Toronto, Canada.
Nash J; Department of Biochemistry, University of Toronto, Toronto, Canada.
Lewis PN; Department of Biochemistry, University of Toronto, Toronto, Canada.
McQuibban GA; Department of Biochemistry, University of Toronto, Toronto, Canada.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2023 Mar 02; Vol. 21 (3), pp. e3001977. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Probucol*/pharmacology
Lipid Droplets*
Animals ; Artificial Intelligence ; Mitophagy ; Zebrafish
Czasopismo naukowe
Tytuł:
Probucol treatment after traumatic brain injury activates BDNF/TrkB pathway, promotes neuroregeneration and ameliorates functional deficits in mice.
Autorzy:
Chen CM; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Gung PY; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Ho YC; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.; Cardiovascular Biology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Hamdin CD; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.; National Health Research Institutes & Department of Life Sciences, National Central University Joint Ph.D. Program in Biomedicine, Taoyuan City, Taiwan.
Yet SF; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2023 Oct; Vol. 180 (20), pp. 2605-2622. Date of Electronic Publication: 2023 Jun 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptor, trkB*/metabolism
Brain Injuries, Traumatic*/drug therapy
Brain Injuries, Traumatic*/metabolism
Mice ; Animals ; Male ; Probucol/pharmacology ; Probucol/therapeutic use ; Tropomyosin ; Brain-Derived Neurotrophic Factor/metabolism ; Nerve Regeneration
Czasopismo naukowe
Tytuł:
Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs.
Autorzy:
Gamit N; Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.
Patil M; Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.
B Sundrappa S; Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.
Sundaram SM; Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.
Sethi G; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Dharmarajan A; Department of Biomedical Sciences, Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Warrier S; Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.; Cuor Stem Cellutions Pvt Ltd, Manipal Institute of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.; Department of Biotechnology, Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Pokaż więcej
Źródło:
Drug development research [Drug Dev Res] 2023 Nov; Vol. 84 (7), pp. 1496-1512. Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/metabolism
Mesenchymal Stem Cells*/metabolism
Animals ; Humans ; Amyloid Precursor Protein Secretases ; Probucol/metabolism ; Drug Evaluation, Preclinical ; Aspartic Acid Endopeptidases
Czasopismo naukowe
Tytuł:
Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
Autorzy:
Abuhassan Q; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, United Kingdom.
Khadra I; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, United Kingdom.
Pyper K; Department of Mathematics and Statistics, University of Strathclyde, Livingstone Tower, 26 Richmond Street, Glasgow G1 1XH, United Kingdom.
Augustijns P; Drug Delivery and Disposition, KU Leuven, ON2, Herestraat 49 Box 921, 3000 Leuven, Belgium.
Brouwers J; Drug Delivery and Disposition, KU Leuven, ON2, Herestraat 49 Box 921, 3000 Leuven, Belgium.
Halbert GW; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, United Kingdom. Electronic address: .
Pokaż więcej
Źródło:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2022 Jul; Vol. 176, pp. 108-121. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article
MeSH Terms:
Intestinal Absorption*
Probucol*
Administration, Oral ; Atazanavir Sulfate ; Hydrogen-Ion Concentration ; Pharmaceutical Preparations/chemistry ; Solubility
Czasopismo naukowe
Tytuł:
Protective Effects of Probucol on Different Brain Cells Exposed to Manganese.
Autorzy:
da Silva EB; Graduada em Medicina, Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, 89600-000, Joaçaba, Brazil.
Eichwald T; Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, 89600-000, Joaçaba, Brazil.
Glaser V; Centro de Ciências Rurais, Coordenadoria Especial de Ciências Biológicas e Agronômicas, Universidade Federal de Santa Catarina (UFSC), Campus de Curitibanos, SC, Curitibanos, Brazil.
Varela KG; Graduada em Ciências Biológicas, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, Biotério, 89600-000, Joaçaba, Brazil.
Baptistella AR; Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, 89600-000, Joaçaba, Brazil.
de Carvalho D; Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, 89600-000, Joaçaba, Brazil.
Remor AP; Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, 89600-000, Joaçaba, Brazil. .
Pokaż więcej
Źródło:
Neurotoxicity research [Neurotox Res] 2022 Feb; Vol. 40 (1), pp. 276-285. Date of Electronic Publication: 2022 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Manganese*/metabolism
Manganese*/toxicity
Probucol*/metabolism
Probucol*/pharmacology
Brain/metabolism ; Cell Line, Tumor ; Humans ; Oxidative Stress
Czasopismo naukowe
Tytuł:
Novel Probucol Analogue, 4,4'-Diselanediylbis (2,6-Di- tert -Butylphenol), Prevents Oxidative Glutamate Neurotoxicity In Vitro and Confers Neuroprotection in a Rodent Model of Ischemic Stroke.
Autorzy:
Jacques MT; Department of Biochemistry, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
de Souza V; Department of Biochemistry, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Barbosa FAR; Department of Chemistry, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Faria Santos Canto R; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre 90050-170, RS, Brazil.
Lopes SC; Department of Pharmacology, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Prediger RD; Department of Pharmacology, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Braga AL; Department of Chemistry, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Aschner M; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, United States.
Farina M; Department of Biochemistry, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Pokaż więcej
Źródło:
ACS chemical neuroscience [ACS Chem Neurosci] 2023 Aug 16; Vol. 14 (16), pp. 2857-2867. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ischemic Stroke*
Neuroprotective Agents*/pharmacology
Rats ; Animals ; Probucol/pharmacology ; Neuroprotection ; Glutamic Acid/toxicity ; Rodentia ; Oxidative Stress ; Oxidants/pharmacology
Czasopismo naukowe
Tytuł:
Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study).
Autorzy:
Lam V; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Clarnette R; Australian Alzheimer's Research Foundation, University of Western Australia, Nedlands, Western Australia, Australia.; School of Medicine, University of Western Australia, Crawley, Western Australia, Australia.
Francis R; School of Medicine, University of Western Australia, Crawley, Western Australia, Australia.; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Bynevelt M; Neurological Intervention and Imaging Service of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Watts G; School of Medicine, University of Western Australia, Crawley, Western Australia, Australia.; Cardiometabolic Service, Department of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.
Flicker L; WA Centre for Health & Ageing, University of Western Australia, Perth, Western Australia, Australia.
Orr CF; Cognitive Clinic, Royal Perth Hospital, Perth, Western Australia, Australia.
Loh P; WA Centre for Health & Ageing, University of Western Australia, Perth, Western Australia, Australia.
Lautenschlager N; Academic Unit of Psychiatry of Old Age, University of Melbourne, Victoria, Victoria, Australia.; North Western Mental Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.; Division of Psychiatry and WA Centre for Health and Ageing, University of Western Australia, Perth, Western Australia, Australia.
Reid CM; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Foster JK; Synapse Neuropsychology, Perth, Western Australia, Australia.; Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.; School of Paediatrics and Child Health, Faculty of Health and Medical Science, University of Western Australia, Crawley, Western Australia, Australia.
Dhaliwal SS; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.; Duke-NUS Medical School, National University of Singapore, Singapore.; Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Robinson S; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Corti E; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Vaccarezza M; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; Curtin Medical School, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.
Horgan B; Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.
Takechi R; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Mamo J; Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia .; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2022 Feb 21; Vol. 12 (2), pp. e058826. Date of Electronic Publication: 2022 Feb 21.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*
Probucol*/pharmacology
Probucol*/therapeutic use
Amyloid beta-Peptides/metabolism ; Animals ; Australia ; Clinical Trials, Phase II as Topic ; Cognition ; Double-Blind Method ; Humans ; Mice ; Quality of Life ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Probucol attenuates NF-κB/NLRP3 signalling and augments Nrf-2 mediated antioxidant defence in nerve injury induced neuropathic pain.
Autorzy:
Derangula K; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Balanagar, India.
Javalgekar M; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Balanagar, India.
Kumar Arruri V; Department of Neurosurgery, University of Wisconsin-Madison, Madison, WI, USA.
Gundu C; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Balanagar, India.
Kumar Kalvala A; College of Pharmacy and Pharmaceutical Science, Florida A&M University, Tallahassee, FL, USA.
Kumar A; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Balanagar, India; National Institute of Pharmaceutical Education and Research (NIPER) Kolkata, Chunnilal Bhavan, 168, Maniktala Main Road, Kolkata, West Bengal, India. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2022 Jan; Vol. 102, pp. 108397. Date of Electronic Publication: 2021 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
NF-E2-Related Factor 2/*metabolism
NF-kappa B/*metabolism
NLR Family, Pyrin Domain-Containing 3 Protein/*metabolism
Neuralgia/*drug therapy
Probucol/*therapeutic use
Signal Transduction/*drug effects
Animals ; Dose-Response Relationship, Drug ; Hyperalgesia/chemically induced ; Male ; Neuralgia/metabolism ; Oxidative Stress/drug effects ; Probucol/administration & dosage ; Rats ; Rats, Sprague-Dawley ; Sciatic Nerve/injuries
Czasopismo naukowe
Tytuł:
Antiviral potential of plant polysaccharide nanoparticles actuating non-specific immunity.
Autorzy:
Stovbun SV; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia.
Kalinina TS; Federal State Budgetary Institution, Research Zakusov Institute of Pharmacology, Moscow, Russia.
Zlenko DV; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia; M.V. Lomonosov Moscow State University, Moscow, Russia; A.N. Severtsov Institute of Ecology and Evolution, Moscow, Russia. Electronic address: .
Kiselev AV; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia.
Litvin AA; Federal Research and Clinical Center of Physical-Chemical Medicine FMBA, Russia.
Bukhvostov AA; N.I. Pirogov Russian, National Research Medical University, Moscow, Russia.
Usachev SV; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia.
Kuznetsov DA; N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia; N.I. Pirogov Russian, National Research Medical University, Moscow, Russia.
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2021 Jul 01; Vol. 182, pp. 743-749. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents*/chemistry
Antiviral Agents*/pharmacokinetics
Antiviral Agents*/pharmacology
Drug Carriers*/chemistry
Drug Carriers*/pharmacokinetics
Drug Carriers*/pharmacology
Nanoparticles*/chemistry
Nanoparticles*/therapeutic use
Polysaccharides*/chemistry
Polysaccharides*/pharmacology
Probucol*/chemistry
Probucol*/pharmacokinetics
Probucol*/pharmacology
COVID-19 Drug Treatment*
Plants/*chemistry
Adolescent ; Adult ; HL-60 Cells ; Humans ; Male ; Phagocytosis/drug effects
Czasopismo naukowe
Tytuł:
Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
Autorzy:
Guo J; Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Ren R; Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Guo Z; Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Sun K; Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
He J; Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Shao J; Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Wang X; Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Mar; Vol. 116, pp. 109820. Date of Electronic Publication: 2023 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Resorption*/drug therapy
Bone Resorption*/etiology
Osteoporosis*/drug therapy
Osteoporosis*/etiology
Female ; Humans ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Cell Differentiation ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; NF-kappa B/metabolism ; Osteoclasts ; Osteogenesis ; Ovariectomy/adverse effects ; Probucol/pharmacology ; Probucol/therapeutic use ; RANK Ligand/metabolism ; Reactive Oxygen Species/metabolism
Czasopismo naukowe
Tytuł:
Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis.
Autorzy:
Tsui L; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China .
Chen L; School of Pharmacy and Medical Technology, Putian University, Putian, Fujian, China.
Ye P; School of Pharmacy and Medical Technology, Putian University, Putian, Fujian, China.
Xu S; School of Pharmacy and Medical Technology, Putian University, Putian, Fujian, China.
Wu SJ; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Chen SC; School of Economics, Qingdao University, Qingdao, Shandong, China.
Xie W; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 May 30; Vol. 13 (5), pp. e068915. Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Niacin*/adverse effects
Drug-Related Side Effects and Adverse Reactions*
Humans ; Gemfibrozil/therapeutic use ; Probucol/therapeutic use ; Cholestyramine Resin/therapeutic use ; Hypolipidemic Agents/adverse effects ; Fibric Acids/adverse effects
Czasopismo naukowe
Tytuł:
Identification of Probucol as a candidate for combination therapy with Metformin for Type 2 diabetes.
Autorzy:
Guttapadu R; IISc Mathematics Initiative, Indian Institute of Science, Bengaluru, Karnataka, 560012, India.
Korla K; Department of Biochemistry, Indian Institute of Science, Bangalore, Karnataka, 560012, India.
Uk S; Department of Pharmacology, K.L.E. University's College of Pharmacy, Bangalore, Karnataka, 560010, India.
Annam V; Department of Pathology, Rajarajeshwari Medical College and Hospital, Bangalore, Karnataka, 560074, India.
Ashok P; Department of Pharmacology, K.L.E. University's College of Pharmacy, Bangalore, Karnataka, 560010, India.
Chandra N; IISc Mathematics Initiative, Indian Institute of Science, Bengaluru, Karnataka, 560012, India. .; Department of Biochemistry, Indian Institute of Science, Bangalore, Karnataka, 560012, India. .; Centre for Biosystems Science and Engineering, Indian Institute of Science, Bengaluru, Karnataka, 560012, India. .
Pokaż więcej
Źródło:
NPJ systems biology and applications [NPJ Syst Biol Appl] 2023 May 23; Vol. 9 (1), pp. 18. Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*
Metformin*
Animals ; Rats ; Probucol ; Gene Expression Profiling ; Oxidative Stress
Czasopismo naukowe
Tytuł:
Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis.
Autorzy:
Zhang S; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Li L; Department of Pharmacy, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
Chen W; Department of Pharmaceutics, College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
Xu S; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Feng X; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zhang L; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.; Department of Pharmacy, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
Pokaż więcej
Źródło:
Phytotherapy research : PTR [Phytother Res] 2021 Jun; Vol. 35 (6), pp. 2945-2967. Date of Electronic Publication: 2020 Dec 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Dietary Supplements*
Antioxidants/*pharmacology
Atherosclerosis/*metabolism
Lipoproteins, LDL/*metabolism
Plant Extracts/*pharmacology
Probucol/*pharmacology
Vitamin E/*pharmacology
Abietanes/pharmacology ; Abietanes/therapeutic use ; Antioxidants/therapeutic use ; Atherosclerosis/drug therapy ; Biological Products/pharmacology ; Biological Products/therapeutic use ; Catechin/analogs & derivatives ; Catechin/pharmacology ; Catechin/therapeutic use ; Humans ; Lycopene/pharmacology ; Lycopene/therapeutic use ; Phytotherapy ; Plant Extracts/therapeutic use ; Probucol/therapeutic use ; Quercetin/pharmacology ; Quercetin/therapeutic use ; Resveratrol/pharmacology ; Resveratrol/therapeutic use ; Vitamin E/therapeutic use
Czasopismo naukowe
Tytuł:
Preventing contrast-induced acute kidney injury with probucol and hydration in patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.
Autorzy:
Cui X; Department of Pharmacy, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Xie B; Department of Cardiology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Wang H; Department of Cardiology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Liu F; Department of Cardiology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Mei L; University of Leeds, Leeds LS2 9JT, UK.
Qin F; Department of Cardiology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Zhang J; Department of Cardiology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Yi X; Department of Pharmacy, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Mar 17; Vol. 102 (11), pp. e33273.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Coronary Disease*
Drug-Related Side Effects and Adverse Reactions*/etiology
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/prevention & control
Acute Kidney Injury*/epidemiology
Humans ; Probucol/therapeutic use ; Contrast Media/adverse effects ; Randomized Controlled Trials as Topic ; Coronary Angiography/adverse effects ; Risk Factors ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
XCR1 T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury.
Autorzy:
Inui H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Nishida M; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Health and Counseling Center, Osaka University, Suita, Japan. Electronic address: .
Ichii M; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
Nakaoka H; Nakaoka clinic, Kakogawa, Japan.
Asaji M; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Ide S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Health and Counseling Center, Osaka University, Suita, Japan.
Saito S; Division of Health Sciences, Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita, Japan.
Saga A; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Omatsu T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Tanaka K; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Kanno K; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Chang J; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Zhu Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Okada T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Okuzaki D; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan.
Matsui T; Department of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.
Ohama T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Department of Dental Anesthesiology, Osaka University Graduate School of Dentistry, Suita, Japan.
Koseki M; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Morii E; Department of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.
Hosen N; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan; Laboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan.
Yamashita S; Rinku General Medical Center, Izumisano, Japan.
Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Pokaż więcej
Źródło:
Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2023 Mar; Vol. 176, pp. 68-83. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Diseases*/metabolism
Heart Injuries*/metabolism
Mice ; Rats ; Animals ; Th1 Cells ; Probucol/metabolism ; Ventricular Remodeling ; Dendritic Cells
Czasopismo naukowe
Tytuł:
Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model.
Autorzy:
Mooranian A; Biotechnology and Drug Development Research Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University , Perth , Australia.
Zamani N; Biotechnology and Drug Development Research Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University , Perth , Australia.
Luna G; Biotechnology and Drug Development Research Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University , Perth , Australia.
Al-Sallami H; School of Pharmacy, University of Otago , Dunedin , New Zealand.
Mikov M; Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad , Novi Sad , Serbia.
Goločorbin-Kon S; Department of Pharmacy, University of Novi Sad , Novi Sad , Serbia.
Stojanovic G; Faculty of Technical Sciences, University of Novi Sad , Novi Sad , Serbia.
Arfuso F; Stem Cell and Cancer Biology Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University , Perth , Australia.
Kovacevic B; Biotechnology and Drug Development Research Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University , Perth , Australia.
Al-Salami H; Biotechnology and Drug Development Research Laboratory, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University , Perth , Australia.
Pokaż więcej
Źródło:
Pharmaceutical development and technology [Pharm Dev Technol] 2019 Dec; Vol. 24 (10), pp. 1272-1277. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Inflammatory Agents/*therapeutic use
Diabetes Mellitus, Experimental/*drug therapy
Diabetes Mellitus, Type 1/*drug therapy
Insulin-Secreting Cells/*drug effects
Probucol/*therapeutic use
Ursodeoxycholic Acid/*therapeutic use
Animals ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/pharmacokinetics ; Drug Combinations ; Drug Compounding ; Excipients/chemistry ; Mice, Inbred BALB C ; Particle Size ; Probucol/administration & dosage ; Probucol/pharmacokinetics ; Tissue Distribution ; Ursodeoxycholic Acid/administration & dosage ; Ursodeoxycholic Acid/pharmacokinetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies